Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine
Susan Richter(University of Auckland), Graeme Eisenhofer(University Hospital Carl Gustav Carus), Aleksandra Kwapiszewska(Institute of Cardiology), Mirko Peitzsch(University Hospital Carl Gustav Carus), Volker Gudziol(University Hospital Carl Gustav Carus), Henri Timmers(Radboud University Nijmegen), Nicole Bechmann(University Hospital Carl Gustav Carus), Charlotte Luths(University Hospital Carl Gustav Carus), Christina Pamporaki(University Hospital Carl Gustav Carus), Aleksander Prejbisz(Institute of Cardiology), Karel Pacák(Endocrine Society), Georgiana Constantinescu(Technische Universität Dresden), Leah Meuter(Stanford Medicine), Mirthe Ghering(Radboud University Nijmegen), Carola Kunath(Technische Universität Dresden), Svenja Nölting(University of Zurich), Bei Qiu(University Hospital Carl Gustav Carus), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Timo Deutschbein(Klinikum Oldenburg)
Cited by 37
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528